TY - JOUR
T1 - Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS
AU - Goldman, Jennifer G
AU - Stebbins, Glenn T.
AU - Leung, Vania
AU - Tilley, Barbara C.
AU - Goetz, Christopher G.
N1 - Funding Information:
PPMI is a public-private partnership funded by The Michael J. Fox Foundation for Parkinson's Research and funding partners including Abbott, Avid Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Covance, Elan, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Merck, Meso Scale Discovery, Pfizer, Roche, and UCB ( www.ppmi-info.org/fundingpartners ). The Rush cohort was funded by the NIH K23NS060949 and Parkinson's Disease Foundation . The MDS-UPDRS Clinimetric study was funded by unrestricted grants to the MDS from Boehringer-Ingelheim (USA) , GlaxoSmithKline , and Pfizer, Inc . The Rush University Medical Center Section of Parkinson Disease and Movement Disorders receives funding and support from the Parkinson's Disease Foundation, New York, NY.
Publisher Copyright:
© 2014 Elsevier Ltd.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background: Non-motor complications of Parkinson's disease (PD), specifically cognitive impairment, sleep disturbances, and fatigue, are recognized as important contributors to poor patient outcomes and quality of life. How sleep problems and fatigue interrelate and impact cognitive function, however, has not systematically been investigated across the stages of PD. The aim of our study was to investigate the relationships among cognitive impairment, night-time sleep problems, daytime sleepiness, and fatigue across all severities of PD. Methods: We examined these non-motor problems using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) in a study of 1319 PD patients drawn from three large cohort studies: the Parkinson's Progressive Markers Initiative, the Rush University PD Cognitive-Behavioral-Imaging study, and the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Clinimetric testing program study, which spanned the gamut of disease, from early to advanced PD. Generalized linear mixed models with logit linking functions and covariates including study cohort, age, PD duration, and presence/absence of PD medications were used to examine relationships between these three non-motor symptoms and cognitive impairment. Results: Of these three frequent, and often inter-twined, non-motor complications, greater daytime sleepiness and fatigue were associated with worse cognitive impairment across the full spectrum of PD (F[16,1158]=2.40 and F[16,1158]=3.45 respectively, p's<0.0005), but an association with night-time sleep was not detected (p=0.83). Conclusions: Given this association of daytime sleepiness and fatigue with cognitive impairment, clinical monitoring for these problems should be considered across all points in the PD spectrum, from early to more advanced disease.
AB - Background: Non-motor complications of Parkinson's disease (PD), specifically cognitive impairment, sleep disturbances, and fatigue, are recognized as important contributors to poor patient outcomes and quality of life. How sleep problems and fatigue interrelate and impact cognitive function, however, has not systematically been investigated across the stages of PD. The aim of our study was to investigate the relationships among cognitive impairment, night-time sleep problems, daytime sleepiness, and fatigue across all severities of PD. Methods: We examined these non-motor problems using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) in a study of 1319 PD patients drawn from three large cohort studies: the Parkinson's Progressive Markers Initiative, the Rush University PD Cognitive-Behavioral-Imaging study, and the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Clinimetric testing program study, which spanned the gamut of disease, from early to advanced PD. Generalized linear mixed models with logit linking functions and covariates including study cohort, age, PD duration, and presence/absence of PD medications were used to examine relationships between these three non-motor symptoms and cognitive impairment. Results: Of these three frequent, and often inter-twined, non-motor complications, greater daytime sleepiness and fatigue were associated with worse cognitive impairment across the full spectrum of PD (F[16,1158]=2.40 and F[16,1158]=3.45 respectively, p's<0.0005), but an association with night-time sleep was not detected (p=0.83). Conclusions: Given this association of daytime sleepiness and fatigue with cognitive impairment, clinical monitoring for these problems should be considered across all points in the PD spectrum, from early to more advanced disease.
KW - Cognitive impairment
KW - Daytime sleepiness
KW - Fatigue
KW - Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=84908575046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908575046&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2014.08.001
DO - 10.1016/j.parkreldis.2014.08.001
M3 - Article
C2 - 25150770
AN - SCOPUS:84908575046
SN - 1353-8020
VL - 20
SP - 1135
EP - 1139
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
IS - 11
ER -